The Magnitude of Dyslipidemia and Factors Associated with Elevated LDL-C Among Black South Africans with Type 2 Diabetes Mellitus at a Tertiary Hospital
Background/Objectives: Type 2 diabetes mellitus (T2DM) is a major global public health challenge with a significant impact on human life. The current study aims to provide a comprehensive analysis of the magnitude of dyslipidemia and the factors associated with elevated LDL-C levels among Black South Africans with T2DM. Methods: This was a cross-sectional study conducted in a tertiary hospital. Blood samples for glycated hemoglobin (HbA1c) and lipid profile were collected from the study participants and analyzed using Siemens Atellica™ analyzer. The data was entered into Microsoft excel and analyzed using SPSS version 24. Bivariate and multivariate logistic regression was employed to identify variables significantly associated with the outcomes, with a p-value ≤ 0.05 and a 95% confidence interval. Results: A total of 194 study participants with T2DM were recruited in the study. The overall prevalence of dyslipidemia was 90.72%. Of those with dyslipidemia, 40.9% had an isolated dyslipidemia, 39.7% had a combined dyslipidemia and 19.3% had atherogenic dyslipidemia. Significant factors associated with elevated levels of LDL-C included age, non-adherence to treatment (NAT) and duration. However, after multivariate analysis, NAT was found to be an independent associated factor with elevated levels of LDL-C (AOR: 4.596; 95% CI: 0.177–2.874; p = 0.027). Conclusions: Our study found that dyslipidemia is highly prevalent among Black South African patients with T2DM at a tertiary hospital, despite the use of lipid-lowering therapy. NAT was significantly associated with elevated levels of LDL-C. However, it is important to note that the study employed a cross-sectional design, conducted at a single hospital, which may impair the generalizability of the findings.
Authors
- Olebogeng H.I. Majane
- Néel Sarovar Bhavesh (ORCID: https://orcid.org/0000-0002-7248-4978)
- Arunkumar Malaisamy (ORCID: https://orcid.org/0000-0003-4398-1534)
- Sechene Stanley Gololo (ORCID: https://orcid.org/0000-0002-8059-1941)
- Mashudu Nemukula (ORCID: https://orcid.org/0000-0001-6384-1286)
- Siphesihle Mkhwanazi
- Tumelo Jessica Mapheto
Institutions
- Sefako Makgatho Health Sciences University (ZA)
- Dr George Mukhari Hospital (ZA)
- International Centre for Genetic Engineering and Biotechnology (IN)
Publication Details
- Journal
- Obesities
- Published
- 2025-09-27
- DOI
- https://doi.org/10.3390/obesities5040070
- Citations
- 1
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Department of Science and Innovation, South Africa
- International Centre for Genetic Engineering and Biotechnology